Paper39051069
[3-Methyladenine alleviates early renal injury in diabetic mice by inhibiting AKT signaling].
Liu B and 7 others. Nan Fang Yi Ke Da Xue Xue Bao, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. [3-Methyladenine alleviates early renal injury in diabetic mice by inhibiting AKT signaling]. Papers, record 39051069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39051069
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- [3-Methyladenine alleviates early renal injury in diabetic mice by inhibiting AKT signaling].
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Experimental | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Diabetic Nephropathies | Major topic |
| Signal Transduction | Major topic |
| Adenine | Major topic |
| Animals | |
| Mice | |
| Kidney | |
| Male | |
| Blood Glucose | |
| Cell Proliferation |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32816106 | YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy. | Acta Diabetol | 2021 | https://conductscience.org/library/papers/32816106 | PubMed |
| 2 | 20123989 | Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20123989 | PubMed |
| 3 | 1600136 | The activated mesangial cell: a glomerular "myofibroblast"? | J Am Soc Nephrol | 1992 | https://conductscience.org/library/papers/1600136 | PubMed |
| 4 | 26404841 | Monomethylated-adenines potentiate glucose-induced insulin production and secretion via inhibition of phosphodiesterase activity in rat pancreatic islets. | Islets | 2015 | https://conductscience.org/library/papers/26404841 | PubMed |
| 5 | 28197212 | Herbal Compound "Jiedu Huayu" Reduces Liver Injury in Rats via Regulation of IL-2, TLR4, and PCNA Expression Levels. | Evid Based Complement Alternat Med | 2017 | https://conductscience.org/library/papers/28197212 | PubMed |
| 6 | 34815154 | Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice. | Phytomedicine | 2022 | https://conductscience.org/library/papers/34815154 | PubMed |
| 7 | 23395679 | 3-Methyladenine induces cell death and its interaction with chemotherapeutic drugs is independent of autophagy. | Biochem Biophys Res Commun | 2013 | https://conductscience.org/library/papers/23395679 | PubMed |
| 8 | 35596156 | Glabridin, a bioactive component of licorice, ameliorates diabetic nephropathy by regulating ferroptosis and the VEGF/Akt/ERK pathways. | Mol Med | 2022 | https://conductscience.org/library/papers/35596156 | PubMed |
| 9 | 37724274 | Effects of autophagy inhibitor 3-methyladenine on a diabetic mice model. | Int J Ophthalmol | 2023 | https://conductscience.org/library/papers/37724274 | PubMed |
| 10 | 32031067 | 3-Methyladenine Inhibits Procollagen-1 and Fibronectin Expression in Dermal Fibroblasts Independent of Autophagy. | Curr Mol Med | 2020 | https://conductscience.org/library/papers/32031067 | PubMed |
| 11 | 22817685 | The autophagic inhibitor 3-methyladenine potently stimulates PKA-dependent lipolysis in adipocytes. | Br J Pharmacol | 2013 | https://conductscience.org/library/papers/22817685 | PubMed |
| 12 | 12707406 | Extracellular matrix metabolism in diabetic nephropathy. | J Am Soc Nephrol | 2003 | https://conductscience.org/library/papers/12707406 | PubMed |
| 13 | 34148304 | Ginkgetin alleviates high glucose-evoked mesangial cell oxidative stress injury, inflammation, and extracellular matrix (ECM) deposition in an AMPK/mTOR-mediated autophagy axis. | Chem Biol Drug Des | 2021 | https://conductscience.org/library/papers/34148304 | PubMed |
| 14 | 27906187 | Systemic application of 3-methyladenine markedly inhibited atherosclerotic lesion in ApoE-/- mice by modulating autophagy, foam cell formation and immune-negative molecules. | Cell Death Dis | 2016 | https://conductscience.org/library/papers/27906187 | PubMed |
| 15 | 33911188 | Reversal of hypertriglyceridemia in diabetic BTBR ob/ob mice does not prevent nephropathy. | Lab Invest | 2021 | https://conductscience.org/library/papers/33911188 | PubMed |
| 16 | 31916058 | Protective effects of autophagy inhibitor 3-methyladenine on ischemia-reperfusion-induced retinal injury. | Int Ophthalmol | 2020 | https://conductscience.org/library/papers/31916058 | PubMed |
| 17 | 16565255 | Renal protection in diabetes: role of glycemic control. | J Am Soc Nephrol | 2006 | https://conductscience.org/library/papers/16565255 | PubMed |
| 18 | 30641802 | Diabetic nephropathy: An update on pathogenesis and drug development. | Diabetes Metab Syndr | 2019 | https://conductscience.org/library/papers/30641802 | PubMed |
| 19 | 25249672 | Diabetic kidney disease: a report from an ADA Consensus Conference. | Diabetes Care | 2014 | https://conductscience.org/library/papers/25249672 | PubMed |
| 20 | 35994821 | Effects of 3-methyladenine, an autophagy inhibitor, on the elevated blood pressure and arterial dysfunction of angiotensin II-induced hypertensive mice. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35994821 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40430426 | Investigating the Effect and Mechanism of 3-Methyladenine Against Diabetic Encephalopathy by Network Pharmacology, Molecular Docking, and Experimental Validation. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40430426 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39051069
GET https://conductscience.org/api/papers/v1/39051069/references?page=2